Back to the future
We catch up with Daiichi Sankyo Europe’s Garth Virgin to discuss cardiovascular disease in the post-COVID landscape
Business Insights
Do you have a new product, new business focus, or a company to showcase?
Increase your exposure with a Business Insight in PharmaTimes Magazine. Our flexible package means you can submit your own copy and photos, or utilise the services of our professional writers and/or photographer to ensure you communicate the best possible message to your audience.
So why not talk to our business development team about Business Insight opportunities with PharmaTimes. After all, a Business Insight in PharmaTimes Magazine offers a unique opportunity to raise your company's profile in the pharmaceutical world.
Why not see what a PharmaTimes Business insight can do for your company?
Contact: anna.yeardley@pharmatimes.com, tel. +44 (0)20 7240 6999.
SMART PEOPLE INSIGHT: Jon Beauchamp
PharmaTimes talks to Jon Beauchamp, Vice President, Head of Medical Affairs at argenx and country manager, UK and Ireland
Monaco: A destination where medical ethics are always respected
For the pharma industry – which relies on confidentiality, clean data, reliable technology and elite presentation options – Monaco offers a peerless package which follows European regulations and compliance guidelines, ensuring that medical ethics are always respected
SMART PEOPLE INSIGHT: Fleur Chandler
Fleur Chandler, Sanofi’s head of market access, UK & Ireland, talks to PharmaTimes about improving outcomes for cancer patients in the UK
Solving this century’s grand challenges
Chemical and biological engineering is coming of age. PharmaTimes talks to Professor James Litster, head of department of chemical and biological engineering at The University of Sheffield
Long and winding road
Time doesn’t stand still in any industry, but throughout pharma the future is always tantalisingly close, requiring companies to reach out, reinvent and realise their potential. Rosemont Pharmaceuticals has been moving with the times for over 50 years
Smart People: Nick Warwick
Nick Warwick, chief medical officer at ADVANZ PHARMA, talks to PharmaTimes about his new role at the firm
Striving for innovation
While there has been tremendous progress in the treatment of rheumatoid arthritis, it remains a debilitating disease that causes a significant socioeconomic impact on societies around the world. As such, researchers are striving to find innovative new treatment options to help more patients reach remission.
AbbVie provided funding and editorial input into this article.
A whole new world
The coronavirus has forced industry to change gear, change how it communicates and, above all, change its perspective. Despite the earth- shattering turbulence of COVID-19, however, Andy Hayley from TBWA\ WorldHealth believes positive lessons and practices will emerge
SmartPeople: Declan Cassells
Cassells has 20 years’ experience in the medical device industry, leading a number of international expansion projects and holding senior management positions in a number of multinational companies including Medtronic, Conor Medsystems, Kinetic Concepts and American Medical Systems. He is now managing director of connected health medtech company Renew Health
Making waves in the GI Market
Jeremy Thorpe, managing director of Tillotts Pharma UK (Tillotts), tells us how his company has entered the UK and grown from strength to strength over the past six years, overcoming numerous challenges to establish Tillotts’ significant presence in the GI market
Quintiles IMS – Communicating in perfect harmony
Rising expectations from payers and prescribers demand a step change in the way companies engage with them
Accretio – Realising the value of rough diamonds
M&A and diversification have left pharma portfolios with an abundance of underinvested medicines, but they needn’t be ignored
KPMG Busting the niche- the future of genomics
The sequencing of patients’ genes has opened the way for exciting new approaches to therapy. The challenge for the pharmaceutical and life sciences sectors is to adapt R&D, production and sales and marketing to become swift, agile developers of more specialised drugs with smaller target audiences
PI Partnership - Learning to GROW
When it comes to the essential task of coaching customer- facing teams, first-line managers need more than just models, tools and templates; they need the right mind-set too
Celebrating a decade of excellence at the BOBI Awards
The often unsung heroes of pharma were celebrated this month as part of the BHBIA's celebration of 10 years of business intelligence excellence
Zenopa - Value added recruitment
Recruitment agencies provide the unique bridge to bring companies and the right candidates together – something recruitment consultancy Zenopa has been doing for the past 25 years
Zenopa - It only takes one applicant to fill a job
Does the tendency to use more than one recruitment agency to fill a vacancy add vIalue or is it counterproductive? Recruitment consultancy Zenopa explores the issue
Zenopa - How to address the industry's skills shortage
Recruitment in the pharmaceutical industry has become a whole new ball game recently. And the pressure to find the right person for the right job is made more difficult by a lack of candidates with the right experience and skills sets across the board.
Covance-Risky business
As clinical trials have become more and more complex, so has trial monitoring - but a risk-based monitoring approach can make it more efficient
Havas Lynx EU - Making patients smile
Research has linked improved wellbeing with a wide-range of health benefits, including better cancer outcomes, lower risk of heart disease and stroke, and stronger immune and endocrine systems.
Royal Bank of Scotland - banking relationship
GROWTH FACTOR - Bharat Shah, Director and Co-founder of Sigma, talks about his experience of growing a business with help from Royal Bank of Scotland
CompliMed - Truth & transparency
Truth & transparency - What pharma needs to keep in mind in the wake of investigations into payments to doctors
Royal Bank of Scotland How to... make the most of your banking relationship
How to... make the most of your banking relationship - In a highly competitive and fast-moving sector, it’s no surprise that pharmaceutical companies need access to finance to stand out from the crowd
CompliMed - Changes to the 2015 Code
Changes to the 2015 Code - The new provisions of the 2015 ABPI Code of Practice will become fully effective from 1 May 2015...
Royal Bank of Scotland - no two businesses are the same
Royal Bank of Scotland: "no two businesses are the same"
RBS' pharma team talks to us about how they are continuing to support the industry – with specialist insight
Ashfield Healthcare – supporting customer and patient outcomes
Ashfield Healthcare offers a wide range of tailored solutions through its unique multi-channel approach to specialised healthcare services. But what makes these services unique? Helen Miles explains
Takeda aims for best in class
Market access and a greater focus on specialist medicines are key to Takeda UK’s drive to be best in class for employees and customers
Pierre Fabre supports patient choice
The relentless pressure on the NHS is felt not just in balance sheets but at the frontline of care. By moving chemotherapy out of the hospital, Pierre Fabre can help both patients and the NHS
Fendix Media Engage with HCPs
Healthcare professionals use the internet every day for a variety of professional purposes from keeping up to date with news, accessing their email and engaging in online communities to completing ongoing CPD courses, or viewing vital clinical resources via their NHS intranets
Local to global making a difference at Pierre Fabre
A family-run company overlaid with the corporate culture of a pharmaceutical multinational may sound like a tricky balancing act. But it can offer the best of both worlds
PI Partnership Learning the new business strategy
Learning: the new business strategy
. Learning and development should be a journey but it should also be part of the company culture and business strategy, says Gary Killington, director of PI Partnership
How can pharma engage directly with HCPs inside the NHS
How can pharma engage directly with HCPs inside the NHS?
With so many different online resources to choose from, the internet is becoming an increasingly competitive space in which to engage with healthcare professionals
PI Partnership The learning journey doesn't stop with training
The learning journey doesn't stop with training.
Pharma needs to invest in its people and look at learning and development not just inside the classroom, but holistically, in order to succeed in the relationship game, says Gary Killington, director of PI Partnership
AstraZeneca
A ground-breaking approach to COPD management – AstraZeneca rolls out their 'intelligent pharmaceuticals' initiative
M3 Europe
Moving 'beyond the push' and offering doctors a smorgasbord of information is the big marketing challenge for pharma, says Dr Tim Ringrose, CEO of M3 Europe
Covance Keeping risk in proportion
Keeping risk in proportion
- Chris Simmons of Covance explains the importance of adopting a risk-based approach to clinical trials
RBS Financing to fit
Financing to fit
. RBS supports healthcare companies through their lifecycle, from start-up to maturity
Best Of Business Intelligence
Market research and data analysis are critical if pharma is to see better outcomes, say the winning entries of this year's Best Of Business Intelligence awards
